Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(3):260-269
Gemifloxacin is a new respiratory fluoroquinolone that was approved as Factive® in Russian Federation in December 2005. Among the fluoroquinolones this agent is the most active against Streptococcus pneumoniae, and has similar to other respiratory …